메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 15, 2026 -- MediCapture Inc., a global leader in medical imaging systems, today announced the launch of aiScope™, software that runs Vision AI models in real-time, locally on MediCapture's MTRs and selected MVR imaging systems. First aiScope™ pilot deployment will be in veterinary science. The technology will be demonstrated live at VMX 2026 in Orlando, Florida, working on MediCapture's VUEES™ University Edition and on portable VUEES™ Mobility platforms. (abbreviated as Veteri
- 김갑성 기자
- 2026-01-15 17:00
AMPLIFON IS A GLOBAL TOP EMPLOYER 2026

Only 17 companies worldwide have earned this recognition for their human resources management practices in 2026. Certification obtained for the first time in the Asia-Pacific region, together with confirmation in Europe, North America, and Latin America. Switzerland, India, China, and Singapore were also certified for the first time MILAN, Jan. 15, 2026 -- Amplifon, the global leader in hearing care services and solutions, is one of 17 companies worldwide certified as a Global Top Employer in 2026, as well as the only company in the hearing care sector to obtain this internatio
- 김갑성 기자
- 2026-01-15 16:30
XA Africa Rebrands to A54, Signaling a New Era for African Tech Investment

[ 메디채널 김갑성 기자 ] The rebranding signals a sharper focus on the African continent for this exclusive angel investor network SINGAPORE, Jan. 15, 2026 -- XA Africa, the exclusive operator-led investment network founded by global technology veterans, today announced its official launch as A54. The rebrand marks a significant milestone in the network's evolution, reflecting its deepened commitment to the 54 nations of the African continent and its growing impact as a primary bridge between global expertise and local innovation. Just over one year since its public launch as XA Africa
- 김갑성 기자
- 2026-01-15 16:00
GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

YONGIN, South Korea, Jan. 15, 2026 -- GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to expand their collaboration and strengthen their position in the global clinical trial market. With the rising proportion of multinational clinical trials, sponsors face varying regulatory requirements, clinical environments, and data d
- 김갑성 기자
- 2026-01-15 15:31
Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry

SINGAPORE, Jan. 15, 2026 -- Docquity, a leading health tech company in Asia, today announced the launch of Docquity Engage™, an AI and Insights-powered market intelligence engine designed to help life sciences companies better understand and optimize engagements with healthcare professional (HCP) audiences. Backed by real-world insights from Docquity's network of more than 500,000 verified doctors across Asia, Docquity Engage™ provides pharmaceutical brand and field teams with real-time visibility into HCP behaviors and preferences, supported by AI-assisted recommendations to enable mo
- 김갑성 기자
- 2026-01-15 13:00
Belief BioMed Congratulates Partner AskBio on IND Acceptance by FDA for Investigational Gene Therapy for Late-Onset Pompe Disease

SHANGHAI, Jan. 15, 2026 -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for AB-1009, an investigational adeno-associated virus (AAV) gene therapy being developed for the treatment of late-onset Pompe disease. With this announcement, the AB-1009 program advances to Phase 1/2, and AskBio initiates a clinical trial in the United States to explore the safety of AB-1009. The company anticipates
- 김갑성 기자
- 2026-01-15 12:11
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

[ 메디채널 김갑성 기자 ] Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clients Complex modalities are WuXi Biologics' core growth engine, with 2/3 of the new integrated projects comprising bispecific/multispecific antibodies and ADCs Bispecific/multispecific antibodies are WuXi Biologics' most exciting, fastest‑growing and highest‑margin engine. With 196 projects in the pipeline, this modality contributes nearly 20% of t
- 김갑성 기자
- 2026-01-15 12:00
Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral 'XAFTY' Following 2026 Biotech Showcase Consensus

- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting Dengue in Vietnam and Respiratory Viruses (Flu, COVID, RSV) in the U.S. with the same drug. - Dr. Davey Smith: "With this multi-virus treatment, 2026 may mark the inaugural year of modern treatments that can treat multiple viruses with one drug, perhaps even viruses that haven't hit us yet." SAN FRANCISCO, Jan. 15, 2026 -- Hyundai Bioscience (KOSDAQ: 048410) today announced a groundbr
- 김갑성 기자
- 2026-01-15 11:34
International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach

BANGKOK, Jan. 15, 2026 -- International Healthcare Week is set to return to Thailand (8-10 July 2026, Queen Sirikit National Convention Center, Bangkok), bringing together the region's most influential health and wellness stakeholders. Organised by Informa Markets, this flagship event will co-locate three major exhibitions: CPHI South East Asia, WHX Bangkok (formerly Medlab Asia and Asia Health), and Medtec Southeast Asia. These events will unite cutting-edge pharmaceutical, medical device, medical laboratory and design and manufacturers of medical devices under one roof, attracting an expect
- 김갑성 기자
- 2026-01-15 10:42
HNC Expo 2025 Concluded Successfully in Shenzhen, Next Stop Shanghai in June 2026

SHENZHEN, China, Jan. 15, 2026 -- During December 16-18, 2025, the "Healthplex Expo, Natural & Nutraceutical Products Shenzhen" (HNC Shenzhen), co-organized by CCCMHPIE and Sinoexpo Informa Markets, was held successfully at the Shenzhen World Exhibition & Convention Center. With Shenzhen as its anchor city, the exhibition fully leveraged the Greater Bay Area's industrial concentration to create a professional platform integrating brand showcase, trend launches, technical exchange and business matchmaking. It drew strong participation from companies across the global health a
- 김갑성 기자
- 2026-01-15 10:00

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2026-03-03_TUE

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 03시 40분